| Literature DB >> 34826547 |
Lucie Chadelle1, Jiaying Liu1, Valérie Choesmel-Cadamuro1, Andrei V Karginov2, Carine Froment3, Odile Burlet-Schiltz3, Sarah Gandarillas4, Yara Barreira4, Christele Segura5, Loïc Van Den Berghe5, Georges Czaplicki3, Nathalie Van Acker6, Florence Dalenc7, Camille Franchet8, Klaus M Hahn2, Xiaobo Wang9, Karine Belguise10.
Abstract
The cytoskeleton and cell-matrix adhesions constitute a dynamic network that controls cellular behavior during development and cancer. The Focal Adhesion Kinase (FAK) is a central actor of these cell dynamics, promoting cell-matrix adhesion turnover and active membrane fluctuations. However, the initial steps leading to FAK activation and subsequent promotion of cell dynamics remain elusive. Here, we report that the serine/threonine kinase PKCθ participates in the initial steps of FAK activation. PKCθ, which is strongly expressed in aggressive human breast cancers, controls the dynamics of cell-matrix adhesions and active protrusions through direct FAK activation, thereby promoting cell invasion and lung metastases. Using various tools for in vitro and live cell studies, we precisely decipher the molecular mechanisms of FAK activation. PKCθ directly interacts with the FAK FERM domain to open FAK conformation through PKCθ's specific V3 domain, while phosphorylating FAK at newly identified serine/threonine residues within nascent adhesions, inducing cell dynamics and aggressive behavior. This study thus places PKCθ-directed FAK opening and phosphorylations as an original mechanism controlling dynamic, migratory, and invasive abilities of aggressive breast cancer cells, further strengthening the emerging oncogenic function of PKCθ.Entities:
Keywords: Cancer cell migration and invasion; Cell dynamics; FAK; PKCθ; Phosphorylation
Mesh:
Substances:
Year: 2021 PMID: 34826547 PMCID: PMC9019305 DOI: 10.1016/j.canlet.2021.11.026
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 9.756